PreXion, a company which values
challenger mindset
and continuous evolution.
After the company’s establishment in 2007, we have promoted the sale of dental diagnostic equipment in the U.S. In 2017, the company started selling in house developed, manufactured, and marketed dental CBCT product, PreXion3D Excelsior, in the U.S.
We have achieved significant sales growth by strengthening our sales network, receiving excellent reputations and feedback from end users for its superior image quality and easy-to-use software, and providing highly satisfactory customer service.
We have started global business expansion with the launch of the PreXion3D EXPLORER series in 2021 and PreXion3D EXPEDITION in 2023,
we will accelerate the expansion of our global business with three global-ready Dental CBCT product lineup.
All our employees have been working together to accurately meet customer needs and provide dental diagnostic CBCT equipment that can be used with peace of mind for many years to come.
2023
Global model with IGZO FPD for further improvement of image quality.
PreXion3D EXPEDITION is launched.
2021
Launched the PreXion3D EXPLORER PRO, a creative and functional all-in-one model with 3D, panoramic and cephalometric.
2019
Launched the PreXion3D EXPLORER as the global expansion model.
Following the U.S. market, proceeded with global expansion, starting with Europe.
January 2017
Launched the Prexion3D Excelsior to the US market, the PreXion’s in-house developed CBCT
August 2015
Changed company name from Xtrillion to PreXion Corporation
February 2015
Presented the photoacoustic imaging system at BiOS (Biophotonics and Biomedical Optic Conference)
November 2014
Started cooperating with Funai Electric Co., Ltd. in medical devices.
Presented the world’s first technology of photoacoustic imaging system using LED.
May 2013
Launched PreXion3D Eclipse in the US market
September 2007
Xtrillion was founded as a spin-off from the cone beam CT technology section of the American company TeraRecon Inc, a leader in advanced medical imaging.